You are here

Heart Failure

 

Patients who suffer brain damage after cardiac arrest could benefit from magnetic resonance (MR) imaging following their stabilization—a measure that has been shown to predict clinical outcomes through mapping brain activity, according to new research published in the American journal Radiology.

Ventricular assist devices (VADs) foster improved survival for children awaiting heart transplantation when compared to the current standard of extracorporeal membrane oxygenation (ECMO), according to a new study in the Journal of the American College of Cardiology.

African Americans are dying an average of 3.4 years before white Americans, a significant gap that’s attributable to more prevalent cardiovascular disease (CVD) and risk factors in the black population, the American Heart Association (AHA) reported in a scientific statement published Monday in Circulation.

Cardiovascular research has traditionally focused on hard clinical endpoints such as markers of disease progression, adverse events and death. But now researchers are calling for more studies that incorporate the viewpoints of patients and caregivers, both in trial design and execution and in measuring outcomes like quality of life, time off work, out-of-pocket expense and caregiver burden.

Digital tracking devices can motivate patients to increase their physical activity outside of structured cardiac rehabilitation, a new study suggests.

 

Recent Headlines

Elderly patients at increased risk for heart failure in cold weather

Elderly patients with a history of cardiovascular disease might want to limit outdoor activities this winter season, according to a group of researchers in Quebec. Their recent study showed that risk of heart failure in older populations can increase as temperature drops.

Lowest volume LVAD centers associated with worse survival

The authors of a new study suggested CMS revise its standards for left ventricular assist device (LVAD) implantation based on patients from the lowest-volume centers demonstrating worse 90-day survival outcomes.

Umbilical cord stem cells could treat heart failure

A new treatment using stem cells from the umbilical cord increased ejection fraction and improved quality of life in heart failure patients, according to a study published in Circulation Research.

Public access to AEDs is growing, so why aren't they being used?

Automated external defibrillators might be increasingly available and encouraged for public use in the case of out-of-hospital cardiac arrests (OHCA), but a study recently published in the European Heart Journal found they aren’t being used nearly as much as they should be.

HER2-targeted breast cancer treatments come with cardiovascular risks

Cardiotoxicity has been documented as a risk in cancer patients undergoing certain breast cancer therapies, but widely accepted international guidelines do not exist for dealing with those complications.

Researchers debut practice of monitoring mitochondria to predict, prevent cardiac arrest

New technology developed by researchers at Boston Children’s Hospital in conjunction with Cambridge-based Pendar Technologies has the ability to monitor oxygen levels in human tissue and predict cardiac arrest in heart patients, a study published in Science Translational Medicine reports.

FDA approves pump to treat right heart failure

The FDA has granted pre-market approval to the Impella RP heart pump used in treating right heart failure, Abiomed announced Sept. 20.

Abbott's PA sensor system is clinically proven to work—but how safe is it?

Recent studies have proven Abbott’s wireless pulmonary artery (PA) sensor CardioMEMS HF System to be successful in reducing heart failure hospitalizations and dramatically lowering medical costs, but a study published in the Journal of the American Medical Association this month questions the safety of the device.

Scientists dissect the reasons behind sudden cardiac death in triathlons

Triathlons could be risky for athletes with heart disease, potentially leading to cardiac arrest or sudden death, according to a new Minneapolis Heart Institute Foundation study.

New heart failure treatment increases ejection fraction by 38% in 1st clinical patient

The first clinical patient to undergo a new, less invasive treatment for heart failure has been discharged from University Hospital Zurich in Switzerland and is recovering well, according to a press release from BioVentrix.

Pages